Company Profile
Founded in 2008, Hangzhou Minsheng Binjiang Pharma(HMBP) is wholely owned by Minsheng Pharma. It got USFDA approval for solid dosage forms since 2011. The annual capacity is around 2billion tablets and 700million capsules equipped with 2 blister lines and a bottle line including Huttlin fluid bed(for pellet coating). HMBP focus on manufacture of solid dosage forms, tablets & capsules, for domestic market and regulated markets.